The global diabetes
devices market size is expected to reach USD 35.5 billion by 2024,
according to a new report by Grand View Research, Inc. The market is projected
to expand at a CAGR of 7.0% during the forecast period. Growing cases of
diabetes, due to obesity, sedentary and unhealthy lifestyles, and several other
factors, is expected to drive demand for diabetes devices over the next few
years.
Obesity is believed to be one of the foremost factors
leading to diabetes in individuals. According to WHO, in 2014, over 1.9 billion
people were identified to be overweight, of which, around 600 million people
were obese.
Some of the key companies in the global diabetes
devices market are Medtronic PLC, Sanofi S.A., Bayer Healthcare AG, Becton,
Dickinson and Company, Novo Nordisk A/S, Abbott Laboratories, F. Hoffman-La
Roche AG, and Johnson & Johnson.
Browse full research report on Diabetes Devices Market: www.grandviewresearch.com/industry-analysis/diabetes-devices-market
Further
key findings from the study suggest:
- Constantly rising target population base is the primary factor
driving market growth
- Test strips capturedthe largest share in the monitoring and
diagnostics device segment while insulin pens accounted for the largest
revenue share among insulin delivery devices in 2016. This can be attributed
to rapid adoption of these user-friendly, quick, and accurate devices for
homecare use
- North America is leading the regional market, followed by Europe.
Advanced healthcare infrastructure and availability of technologically
advanced products have driven the regional market
- Key players in the market include Medtronic PLC, Sanofi S.A., Bayer
Healthcare AG, Becton Dickinson and Company, Novo Nordisk A/S, Abbott
Laboratories, F. Hoffman-La Roche AG and Johnson & Johnson.
Browse more reports of this category
by Grand View Research: www.grandviewresearch.com/industry/medical-devices
Grand
View Research has segmented the global diabetes devices market on the basis of
product type and region:
Diabetes
Devices Product Type Outlook (Revenue, USD Million, 2014 - 2024)
- Monitoring
and Diagnostic Devices
- Lancets
- Analog
Glucose Monitor
- Continuous
Glucose Monitor
- Test Strips
- Insulin
Delivery Devices
- Syringe
- Pens
- Pumps
- Injectors
Diabetes
Devices Regional Outlook (Revenue, USD Million, 2014 - 2024)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Asia Pacific
- China
- India
- Latin America
- Mexico
- Brazil
- MEA
- UAE
About Grand View
Research
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com
No comments:
Post a Comment